Dehydroeffusol inhibits hypoxia-induced epithelial–mesenchymal transition in non-small cell lung cancer cells through the inactivation of Wnt/β-catenin pathway

Dehydroeffusol (DHE) is a phenanthrene compound that possesses anti-tumor activity. However, the effect of DHE on non-small cell lung cancer (NSCLC) has not been investigated previously. Therefore, the objective of our study was to explore the role of DHE in NSCLC and the underlying mechanism. Our r...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Haitao, Zhang, Feng, Wang, Jiali, Zhao, Min, Hou, Tao, Li, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256677/
https://www.ncbi.nlm.nih.gov/pubmed/32426814
http://dx.doi.org/10.1042/BSR20194284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256677/
https://www.ncbi.nlm.nih.gov/pubmed/32426814
http://dx.doi.org/10.1042/BSR20194284

Ejemplares similares